Skip to content

EXOZ EXOZ Change in AP

Change in AP at other companies

Gevo logo
GevoGEVO
-$9.83M-2,339%
NAG
Niagen Bioscience, Inc. Common StockNAGE
$2.48M+17.8%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$1M+55.7%
Opko Health logo
Opko HealthOPK
$3.5M-69.5%
Upexi logo
UpexiUPXI
$231.13K-55.4%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$4.48M+517%

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%
EPS (diluted)-$0.28-27.3%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$76.8M-3.3%
Enterprise value$76.57M+3.5%
P/S1,096.1×

Profitability

See full
Operating margin-14,489.6%
Net margin-2,909.1%
FCF margin-10,117.8%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by EXOZ in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities.

The official record: EXOZ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about EXOZ's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EXOZ's change in AP?
EXOZ (EXOZ) reported change in AP of -$1.26K in Q1 2026.
How has EXOZ's change in AP changed year-over-year?
EXOZ's change in AP decreased by 100.9% year-over-year, from $147.55K to -$1.26K.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.